News
36m
Asianet Newsable on MSNEli Lilly Inks Up To $1.3B Deal With Superluminal Medicines To Develop Obesity Drugs
Eli Lilly (LLY) has entered into a deal worth up to $1.3 billion with drug discovery company Superluminal Medicines to ...
Eli Lilly will raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170% to be in line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results